interest in Aceon and other ACE inhibitors for patients with coronary heart disease
October 2003
You'll see more interest in Aceon and other ACE inhibitors for patients with coronary heart disease.
This trend started a few years ago when the huge "HOPE" trial brought to light the benefits of Altace (ramipril) for heart disease...even in patients who DON'T have hypertension or heart failure.
Now we know that Aceon (perindopril) has similar benefits. It reduces the risk of heart attacks and cardiovascular death in patients with coronary heart disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote